HomeTechEquipmentEli Lilly (LLY) Hits High After Diabetes Drug Approval

Eli Lilly (LLY) Hits High After Diabetes Drug Approval

Eli Lilly (LLY) is higher after Chinese regulators approve diabetes drug in China. Diane King Hall discusses this as Eli Lilly’s Phase 3 study of Crohn’s disease treatment achieves “meaningful improvements.” Eli Lilly hit a new all-time high today. Tune in to find out more about the stock market today.

Next Gen Investing

21 May 2024

SHARE

ON AIR
7:00 am
Futures
12:00 am
Fast Market
REPLAY
1:00 am
Next Gen Investing
REPLAY
2:00 am
Trading 360
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
5:30 am
Market Overtime
REPLAY
6:00 am
Fast Market
REPLAY
ON AIR
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
education
4:00 pm
Inside the Mind of a Trader
REPLAY
4:30 pm
Market Overtime
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Inside the Mind of a Trader
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Fast Market
REPLAY
education
9:00 pm
Inside the Mind of a Trader
REPLAY
9:30 pm
Market Overtime
REPLAY
education
10:00 pm
Your First Trade
REPLAY
10:30 pm
Market Overtime
REPLAY
11:00 pm
Trading 360
REPLAY

Get the Market Minute

Daily insights for every investor